Literature DB >> 35858440

Proton transfer activity of the reconstituted Mycobacterium tuberculosis MmpL3 is modulated by substrate mimics and inhibitors.

Casey M Stevens1, Svitlana O Babii1, Amitkumar N Pandya2, Wei Li3, Yupeng Li4,5,6, Jitender Mehla1, Robyn Scott2, Pooja Hegde2, Pavan K Prathipati2, Atanu Acharya6, Jinchan Liu4,5,6, James C Gumbart6, Jeffrey North2, Mary Jackson3, Helen I Zgurskaya1.   

Abstract

Transporters belonging to the Resistance-Nodulation-cell Division (RND) superfamily of proteins such as Mycobacterium tuberculosis MmpL3 and its analogs are the focus of intense investigations due to their importance in the physiology of Corynebacterium-Mycobacterium-Nocardia species and antimycobacterial drug discovery. These transporters deliver trehalose monomycolates, the precursors of major lipids of the outer membrane, to the periplasm by a proton motive force-dependent mechanism. In this study, we successfully purified, from native membranes, the full-length and the C-terminal truncated M. tuberculosis MmpL3 and Corynebacterium glutamicum CmpL1 proteins and reconstituted them into proteoliposomes. We also generated a series of substrate mimics and inhibitors specific to these transporters, analyzed their activities in the reconstituted proteoliposomes, and carried out molecular dynamics simulations of the model MmpL3 transporter at different pH. We found that all reconstituted proteins facilitate proton translocation across a phospholipid bilayer, but MmpL3 and CmpL1 differ dramatically in their responses to pH and interactions with substrate mimics and indole-2-carboxamide inhibitors. Our results further suggest that some inhibitors abolish the transport activity of MmpL3 and CmpL1 by inhibition of proton translocation.

Entities:  

Keywords:  drug target; membrane transporter; reconstitution; tuberculosis

Mesh:

Substances:

Year:  2022        PMID: 35858440      PMCID: PMC9335285          DOI: 10.1073/pnas.2113963119

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   12.779


  59 in total

Review 1.  The diverse family of MmpL transporters in mycobacteria: from regulation to antimicrobial developments.

Authors:  Albertus Viljoen; Violaine Dubois; Fabienne Girard-Misguich; Mickaël Blaise; Jean-Louis Herrmann; Laurent Kremer
Journal:  Mol Microbiol       Date:  2017-04-18       Impact factor: 3.501

2.  Contribution of the Mycobacterium tuberculosis MmpL protein family to virulence and drug resistance.

Authors:  Pilar Domenech; Michael B Reed; Clifton E Barry
Journal:  Infect Immun       Date:  2005-06       Impact factor: 3.441

3.  The reductase that catalyzes mycolic motif synthesis is required for efficient attachment of mycolic acids to arabinogalactan.

Authors:  David J Lea-Smith; James S Pyke; Dedreia Tull; Malcolm J McConville; Ross L Coppel; Paul K Crellin
Journal:  J Biol Chem       Date:  2007-02-17       Impact factor: 5.157

Review 4.  Lipid transport in Mycobacterium tuberculosis and its implications in virulence and drug development.

Authors:  Rebeca Bailo; Apoorva Bhatt; José A Aínsa
Journal:  Biochem Pharmacol       Date:  2015-05-16       Impact factor: 5.858

5.  Indole-2-Carboxamides Are Active against Mycobacterium abscessus in a Mouse Model of Acute Infection.

Authors:  Amit N Pandya; Pavan K Prathipati; Pooja Hegde; Wei Li; Kyle F Graham; Subhra Mandal; Kristen M Drescher; Christopher J Destache; Diane Ordway; Mary Jackson; E Jeffrey North
Journal:  Antimicrob Agents Chemother       Date:  2019-02-26       Impact factor: 5.191

6.  Antiinfectives targeting enzymes and the proton motive force.

Authors:  Xinxin Feng; Wei Zhu; Lici A Schurig-Briccio; Steffen Lindert; Carolyn Shoen; Reese Hitchings; Jikun Li; Yang Wang; Noman Baig; Tianhui Zhou; Boo Kyung Kim; Dean C Crick; Michael Cynamon; J Andrew McCammon; Robert B Gennis; Eric Oldfield
Journal:  Proc Natl Acad Sci U S A       Date:  2015-12-07       Impact factor: 11.205

7.  Therapeutic Potential of the Mycobacterium tuberculosis Mycolic Acid Transporter, MmpL3.

Authors:  Wei Li; Andrés Obregón-Henao; Joshua B Wallach; E Jeffrey North; Richard E Lee; Mercedes Gonzalez-Juarrero; Dirk Schnappinger; Mary Jackson
Journal:  Antimicrob Agents Chemother       Date:  2016-08-22       Impact factor: 5.191

8.  The three Mycobacterium tuberculosis antigen 85 isoforms have unique substrates and activities determined by non-active site regions.

Authors:  Keriann M Backus; Michael A Dolan; Conor S Barry; Maju Joe; Peter McPhie; Helena I M Boshoff; Todd L Lowary; Benjamin G Davis; Clifton E Barry
Journal:  J Biol Chem       Date:  2014-07-14       Impact factor: 5.157

9.  Multitarget drug discovery for tuberculosis and other infectious diseases.

Authors:  Kai Li; Lici A Schurig-Briccio; Xinxin Feng; Ashutosh Upadhyay; Venugopal Pujari; Benoit Lechartier; Fabio L Fontes; Hongliang Yang; Guodong Rao; Wei Zhu; Anmol Gulati; Joo Hwan No; Giovana Cintra; Shannon Bogue; Yi-Liang Liu; Katie Molohon; Peter Orlean; Douglas A Mitchell; Lucio Freitas-Junior; Feifei Ren; Hong Sun; Tong Jiang; Yujie Li; Rey-Ting Guo; Stewart T Cole; Robert B Gennis; Dean C Crick; Eric Oldfield
Journal:  J Med Chem       Date:  2014-04-01       Impact factor: 7.446

Review 10.  Mycolic acids: deciphering and targeting the Achilles' heel of the tubercle bacillus.

Authors:  Vijayashankar Nataraj; Cristian Varela; Asma Javid; Albel Singh; Gurdyal S Besra; Apoorva Bhatt
Journal:  Mol Microbiol       Date:  2015-07-30       Impact factor: 3.501

View more
  1 in total

1.  The driving force for mycolic acid export by mycobacterial MmpL3 is proton translocation.

Authors:  Tanya Parish
Journal:  Proc Natl Acad Sci U S A       Date:  2022-08-08       Impact factor: 12.779

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.